EP2247282
SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.1.2009EP published:
20.8.2014EP application number:
09705454.8
EPO information:
European Patent Register
Max expiry date:
28.1.2029
Title:
SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS
Timeline
Today
29.1.2009EP application
20.8.2014EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
PETERSEN, HolgerAddress:
Eimeldingen, DE
Name:
AHLHEIM, MarkusAddress:
Staufen, DE
Priority
Number:
08150826Date:
30.1.2008Country:
EP
Classification
Categories:
A61K 9/00, A61K 9/06, A61K 9/10, A61K 9/16, A61K 47/34, A61K 38/31